The ITA reports that the Mexican triathlete Tomás Rodríguez Hernández has accepted a 2-year period of ineligibility as a consequence of his anti-doping rule violation

The International Testing Agency (ITA) on behalf of IRONMAN reports that Tomás Rodríguez Hernández, a triathlete from Mexico, has been sanctioned with a two-year period of ineligibility for an anti-doping rule violation (“ADRV”) under Article 2.1 of the IRONMAN Anti-Doping Rules (“IRONMAN ADR”) for the Presence of Clomifene.

As previously announced, the Athlete provided a sample under the Testing Authority and Results Management Authority of IRONMAN during an In-Competition anti-doping control at the 2024 IRONMAN Texas on 27 April 2024 which upon analysis, was positive for Clomifene.

Clomifene is a Specified Substance prohibited under class S4. Hormone and Metabolic Modulators of the World Anti-Doping Agency’s Prohibited List. Clomifene has the potential effects of boosting or restoring Testosterone production and thus increasing muscle mass.

Tomás Rodríguez Hernández was under Provisional Suspension and accepted the ADRV and agreed with the Consequences determined by the ITA as per the IRONMAN ADR, namely a two-year period of Ineligibility¹ as from 6 June 2024 until 5 June 2026 and disqualification of all his competitive results as from 27 April 2024.

Accordingly, this case was resolved via an Agreement on Consequences pursuant to Article 8.3.1 of the IRONMAN ADR.

The ITA reports that the Mexican triathlete Tomás Rodríguez Hernández has accepted a 2-year period of ineligibility as a consequence of his anti-doping rule violation

Share

Talk to Us

Subscribe

Media Centre

Cookie Policy & Privacy Notice